DZ-13

N/A

Report date: 2022/03/16 15:47:59
NME

Base Information

Drug NameDZ-13
Drug Alias NameDNAzyme targeting the c-Jun mRNADZ13DZ-13
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionVascular cell adhesion molecule 1 inhibitorsCaspase-2 activators
TargetsVascular cell adhesion molecule 1Caspase-2
Therapy Area/IndicationsCarcinoma, Basal CellMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of New South WalesRoyal Prince Alfred Hospital
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of New South WalesRoyal Prince Alfred Hospital
Active IndicationsN/A
Inactive IndicationsCarcinoma, Basal CellMelanoma

Other Information

ATC CodeN/A
Related LinksN/A